AIDS and HIV infection
Featured projects
-
Micro-eliminación de la infección por el VHC en el colectivo de HSH/VIH+ en Barcelona
Principal investigator: Montserrat Laguno Centeno.Duration: 01/01/2018 - 31/12/2021Red Temática de Investigación Cooperativa en Salud - SIDA (RIS)
Principal investigator: Felipe García.Funder: Institut d`Investigacions Biomèdiques August Pi i Sunyer (Sede); Red temàtica cooperativa de investigación en salud (ISCIII) .Code: RD16/0025/0014.Duration: 01/01/2017 - 31/01/2021Evaluating a Combination of Immune-based Therapies to Achieve a Functional Cure of HIV Infection (HIVACAR)
Funder: Hospital Clínic i Provincial de Barcelona/IDIBAPS (Sede); H2020-SC1-2016-2017 .Duration: 01/01/2017 - 01/01/2021European AIDS Vaccine Initiative 2020 (EAVI2020)
Funder: Hospital Clínico de Barcelona (Sede); European Comission H2020-PHC-2015 .Code: 681137.Duration: 01/01/2016 - 01/01/2019European HIV Vaccine Alliance (EHVA): an EU platform for the discovery and evaluation of novel prophylactic and therapeutic vaccine candidates
Principal investigator: Felipe Garcia Alcaide.Funder: Hospital Clínico de Barcelona (Sede); CE_H2020-PHCRTD-15 .Code: 681032.Duration: 01/01/2016 - 31/12/2020Evaluating mHealth technology in HIV to improve Empowerment and healthcare utilisation: Research and innovation to Generate Evidence for personalised care. (EMERGE)
Principal investigator: Felipe Garcia Alcaide.Funder: HOSPITAL CLINICO Y PROVINCIAL DE BARCELONA (Sede); European Comission ; European Comission CE_H2020-PHC-2014-1s .Code: CE_H2020-PHC-2014-1s.Duration: 01/01/2015 - 01/01/2019Ensayo clínico abierto de fase III para evaluar la eficacia y la seguridad del régimen en combinación de MK 5172/MK 5742 en sujeros con infección crónica por el VHC GT1, GT4 GT5 y GT6 y coinfección por el VIH no tratados previamente
Principal investigator: Josep Mallolas Masferrer.Funder: Universitat de Barcelona (Sede); Merck Sharp & Dohme Research Laboratories ; Fundació Clínic per a la Recerca Biomèdica (Participante).Code: HCP/14/283.Duration: 29/04/2014Catalan Program for the development of a HIV vaccine (HIVACAT)
Funder: Hospital Clínic i Provincial de Barcelona/IDIBAPS (Sede).Duration: 01/01/2014 - 01/01/2017Major founders
The research of this group can be carried out thanks to the funders.
-
. This link opens in a new tab. Abbvie
-
. This link opens in a new tab. CIBER-ISCIII
-
. This link opens in a new tab. European Commission
-
. This link opens in a new tab. Fundació ”la Caixa”
-
. This link opens in a new tab. Gilead
-
. This link opens in a new tab. Janssen
-
. This link opens in a new tab. MSD
-
. This link opens in a new tab. Viiv
More about researchCheck job offersIDIBAPS-FCRB looks for talented professionals to meet the needs that appear periodically.
Enter